The use of medicinal herbs may cause serious nephrologic and urologic diseases;El uso de hierbas medicinales puede producir graves problemas nefrológicos y urológicos

Actas Urologicas Espanolas

Volumn 29, Issue 8, 2005, Pages 801-802

  Toro, O Arango ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICALLY INDUCED DISORDER; HERBAL MEDICINE; HUMAN; KIDNEY DISEASE; METHODOLOGY; NOTE; PHYTOTHERAPY; URINARY TRACT DISEASE;

HUMANS; KIDNEY DISEASES; MEDICINE, HERBAL; PHYTOTHERAPY; UROLOGIC DISEASES;

EID: 33644813085     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(05)73346-5     Document Type: Review

References (13)

1. Tanaka A, Shinkal S, Kasuno K, et al. Chinese herbs nephropathy in the Kansai area: a warning report. Jpn J Nephrol 1997:39:438-440.
2. Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999; 354:481-482.
3. Yang C-S, Lin C-H, Chang S-H, Hsu H-C. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000;35:313-318.
4. Pourrat J, Montastruc JL, Lacombe JL, Cisterne JM, Rascol O, Dumazer P. Nephropathy associated with Chinese herbal drugs. 2 cases. Presse Med 1994; 23:1669-1670
5. Peña JM, Borrás M, Ramos J, Montoliu J. Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia. pistolochia) infusion. Nephrol Dial Transplant 1996:11:1359-1360.
6. Mortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-1692.
7. Martinez MCM, Nortier JL, Vereerstraeten P, Vanherweghem, JL. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol Dial Transplant 2002:17:408-412.
8. Mortier JL, Schmeiser HH, Martinez MCM, Arlt VM, Vervaet C, Garbar CH, et al. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. Nephrol Dial Transplant 2003;18:426-428.
9. Schmeiser HH, Bieler CA, Wiessler M, Ypersele de Strihou C van, Cosyns JP. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Research 1996:56:2025-2028.
10. Stiborova M, Frei E, Sopko B, Wiessler M, Schmeiser HH. Carcinogenic aristolochic acids upon activation by DT-diap-horase form adducts found in DNA of patients with Chinese herbs nephropathy. Carcinogenesis 2002;23:617-625.
11. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002:17:265-277.
12. Cui M, Liu ZH, Qiu Q, Li H, Li LS. Tumour induction in rats following exposure to short-term high dose aristolochic acid I. Mutagenesis 2005:20:45-49.
13. Fleshner N, Harvey M, Adomat H, Wood C, Eberding A, Hersey K, Guns E. Evidence for contamination of herbal erectile dysfunction products with phosphodiesterase types 5 inhibitors. J Urol 2005;174:636-641.